Jacksonville Bancorp, Inc. (JXSB) Declares Dividend
Mar 15, 2016 20:53 pm UTC| Business
JACKSONVILLE, Ill., March 15, 2016 -- Andrew F. Applebee, Chairman of Jacksonville Bancorp, Inc. (Nasdaq:JXSB), (the "Bancorp") today announced that the Bancorp has declared our quarterly cash dividend of $0.10 per...
Lexington Realty Trust Announces Quarterly Common Share Dividend
Mar 15, 2016 20:51 pm UTC| Business
NEW YORK, March 15, 2016 -- Lexington Realty Trust (NYSE:LXP) (“Lexington”), a real estate investment trust (REIT) focused on single-tenant real estate investments, today announced that it declared a regular common...
Mar 15, 2016 20:49 pm UTC| Business
NEW YORK, March 15, 2016 -- Harris Harris Group, Inc. (NASDAQ:TINY), reported today that, as of December 31, 2015, its net asset value and net asset value per share were $88,711,671 and $2.88, respectively. The...
SP+ Municipal Services Selected to Manage Parking and Transportation Program for Annapolis
Mar 15, 2016 20:45 pm UTC| Business
CHICAGO, March 15, 2016 -- SP Plus Corporation (SP+), (Nasdaq:SP), a leader in parking management, ground transportation and ancillary services, announced that SP+ Municipal Services has been awarded a long-term...
Xtant™ Medical Reports Record $22.3 Million Revenue and 14.1% Growth for the Fourth Quarter 2015
Mar 15, 2016 20:31 pm UTC| Business
See footnote about the use of pro forma financial information Fourth Quarter 2015 Highlights: Consolidated total revenue increased 14.1% to a record $22.3 million compared to pro forma fourth quarter 2014 revenue of...
magicJack Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 15, 2016 20:30 pm UTC| Business
Total net revenues of $101.0 million during FY15Access rights renewal revenues were $65.8 million in FY15FY15 GAAP operating income of $25.3 million, Adjusted EBITDA of $37.0 millionFY15 GAAP diluted EPS of $0.79, non-GAAP...
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results
Mar 15, 2016 20:30 pm UTC| Business
CORAL GABLES, Fla., March 15, 2016 -- Catalyst Pharmaceuticals, Inc.(Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating...